Verona Pharma Plc ADR (NASDAQ: VRNA) kicked off on Monday, up 5.15% from the previous trading day, before settling in for the closing price of $65.46. Over the past 52 weeks, VRNA has traded in a range of $11.39-$70.40.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -39.77%. While this was happening, its average annual earnings per share was recorded 128.52%. With a float of $74.18 million, this company’s outstanding shares have now reached $84.63 million.
The extent of productivity of a business whose workforce counts for 209 workers is very important to gauge. In terms of profitability, gross margin is 92.63%, operating margin of -365.87%, and the pretax margin is -389.38%.
Verona Pharma Plc ADR (VRNA) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Verona Pharma Plc ADR is 12.34%, while institutional ownership is 70.57%. The most recent insider transaction that took place on Mar 12 ’25, was worth 661,942. In this transaction Chief Medical Officer of this company sold 79,264 shares at a rate of $8.35, taking the stock ownership to the 2,608,976 shares. Before that another transaction happened on Mar 12 ’25, when Company’s Officer proposed sale 9,908 for $62.70, making the entire transaction worth $621,232.
Verona Pharma Plc ADR (VRNA) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.02 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 128.52% per share during the next fiscal year.
Verona Pharma Plc ADR (NASDAQ: VRNA) Trading Performance Indicators
Take a look at Verona Pharma Plc ADR’s (VRNA) current performance indicators. Last quarter, stock had a quick ratio of 10.48. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 138.69.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.16, a number that is poised to hit -0.08 in the next quarter and is forecasted to reach 0.56 in one year’s time.
Technical Analysis of Verona Pharma Plc ADR (VRNA)
The latest stats from [Verona Pharma Plc ADR, VRNA] show that its last 5-days average volume of 1.38 million was inferior to 1.45 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 89.23%. Additionally, its Average True Range was 3.69.
During the past 100 days, Verona Pharma Plc ADR’s (VRNA) raw stochastic average was set at 95.09%, which indicates a significant decrease from 97.74% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 51.42% in the past 14 days, which was lower than the 57.55% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $62.93, while its 200-day Moving Average is $42.89. Now, the first resistance to watch is $70.23. This is followed by the second major resistance level at $71.63. The third major resistance level sits at $73.95. If the price goes on to break the first support level at $66.51, it is likely to go to the next support level at $64.20. Assuming the price breaks the second support level, the third support level stands at $62.80.
Verona Pharma Plc ADR (NASDAQ: VRNA) Key Stats
The company with the Market Capitalisation of 5.83 billion has total of 80,820K Shares Outstanding. Its annual sales at the moment are 42,280 K in contrast with the sum of -173,420 K annual income. Company’s last quarter sales were recorded 36,660 K and last quarter income was -33,830 K.
